Australia's Osteopore gains on deal to sell products in China

Osteopore

23/08/2022 03:15

** Shares of Osteopore  OSX.AX  jump as much as 13.6% to
A$0.235, their highest since Aug 10 
    ** The bone healing implant maker says it has signed a deal
with Kontour (Xi'an) Medical Technology to market and sell its
products within China 
    ** Adds that Kontour has agreed to a purchase target of
$500,000 of Osteopore products in the first year after National
Medical Products Administration clearance, and $1 mln in the
second year 
    ** Shares set for best day since Aug 12, if gains hold 
    ** Osteopore stock down ~2.2% this year, as of last close

    ($1 = 1.4510 Australian dollars)

 (Reporting by Archishma Iyer)
 ((Archishma.Iyer@thomsonreuters.com;))